Spain· ES:00134004
LANTUS 100 UNIDADES/ML SOLUCION INYECTABLE EN UN VIAL
A medicinal product containing insulina glargina, registered in Spain by Sanofi-Aventis Deutschland Gmbh.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- insulina glargina
- Manufacturer
- Sanofi-Aventis Deutschland Gmbh
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 3, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Insulina glargina in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaABASAGLAREli Lilly Nederland B.V., Utrecht
- United KingdomAbasaglar 100units/ml solution for injection 3ml cartridgesEli Lilly and Company Ltd
- United StatesBASAGLAREli Lilly and Company
- BelgiumAbasaglar 100 U/mlEli Lilly Nederland
- FinlandABASAGLAREli Lilly Nederland B.V.
- IrelandABASAGLAR 100 units/mL solution for injection in a cartridgeEli Lilly Nederland B.V.
- SwedenABASAGLAR 100 enheter/ml Injektionsvätska, lösning i cylinderampullEli Lilly Nederland B.V.
- CanadaBASAGLARELI LILLY CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Abasaglar, Abasaglar Kwikpen
- Liechtenstein · Abasaglar, Abasaglar Kwikpen
- Norway · Lantus, Lantus Solostar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5892cff-1355-4739-a051-9d01fe2b8133 GET /v1/drugs/f5892cff-1355-4739-a051-9d01fe2b8133?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración",
"estado": "{\"aut\":974156400000}",
"nregistro": "00134004",
"substance": "insulina glargina"
}See everything about insulina glargina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.